OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
53 hedge funds and large institutions have $189M invested in Oyster Point Pharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
42% less call options, than puts
Call options by funds: $631K | Put options by funds: $1.08M
Holders
53
Holding in Top 10
2
Calls
$631K
Puts
$1.08M
Top Buyers
| 1 | +$7.32M | |
| 2 | +$7.27M | |
| 3 | +$5.76M | |
| 4 |
Man Group
London,
United Kingdom
|
+$3.57M |
| 5 |
RI
RTW Investments
New York
|
+$2.91M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.26M | |
| 3 | -$5.61M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.62M |
| 5 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
-$4.37M |